Search results for: “sanofi”
-
Sanofi to invest €400 million annually in dedicated vaccines mRNA Center of Excellence
•
PARIS, FRANCE: Sanofi SA will invest approximately €400 million annually in a first-of-its kind vaccines mRNA Center of…
-
Sanofi completes acquisition of Kiadis Pharma
•
AMSTERDAM: Sanofi has completed the acquisition of Kiadis, a clinical-stage biopharmaceutical company developing next generation ‘off-the-shelf’ NK cell-therapies,…
-
Sanofi to create a €400 million vaccine production center in Singapore
•
PARIS: Sanofi announced a €400 million investment over five years to create a unique vaccine production center in…
-
Schroder UK sells its stake in Kymab Group to Sanofi for $82 million
•
LONDON: Schroder UK Public Private Trust (SUPP) has sold of its shares in Kymab Group Ltd. to Sanofi…
-
Sanofi creates nonprofit unit to provide poorest countries with access to essential medicines
•
PARIS: Sanofi Chief Executive Officer Paul Hudson outlined several key projects that the company will implement to increase…
-
Sanofi, Capgemini, Generali and Orange to create e-health digital ecosystem
•
PARIS: Sanofi, Capgemini, Generali and Orange are forming a joint venture in France to fast-track the development of…
-
Sanofi to acquire Kymab for an upfront payment of approximately $1.1 billion
•
PARIS: Sanofi and Kymab, a clinical-stage biopharmaceutical company developing fully human monoclonal antibodies with a focus on immune-mediated…
-
Sanofi and GSK in to supply EU with 300m COVID-19 vaccines doses
•
LONDON: Sanofi and GSK are in advanced discussions with the European Commission (EC) for the supply of up…
-
Sanofi and GSK agree with the UK government to supply up to 60 million doses of COVID-19 vaccine
•
LONDON: Sanofi and have reached an agreement, subject to final contract, with the UK government for the supply…
-
HighRadius acquires Cforia Software to expand its autonomous finance solutions
•
HighRadius, the leading provider of cloud-based autonomous software for the office of the CFO, announced the acquisition of…
-
AQEMIA raises €60M to boost its AI-powered drug discovery platform and pipeline
•
AQEMIA, a tech-enabled drug discovery company that uses generative AI and deep physics to find new drugs, has…
Stay Informed with the Latest News and Updates
- Contact Us
- London Stock Exchange
- Singapore Exchange
- Canadian Exchange
- Australian Exchange
- Oslo Bourse
- PSX
- Ratings
- Euronext
- MENA
- Nasdaq Nordic
- Wire
- Business & Finance
- Gadget Reviews
- About Us: A Comprehensive Financial News Database
All news and articles on NewsnReleases are based on press releases, corporate announcements and analysts’ reports issued to London Stock Exchange (LSE), Euronext, Singapore Exchange (SGX), Japan Stock Exchange (JPX), Dubai Financial Market (DFM), Saudi Stock Exchange (Tadawul), Qatar Stock Exchange (QSE), BSEIndia, Australia Stock Exchange etc.